This inventor holds 8 USPTO granted patents. Top assignees: Nanogen Recognomics Gmbh, Aventis Research & Technologies Gmbh & Co Kg, Gpc Biotech Ag. Active years: 2003-2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
6 out of 16 
1 out of 62 
1 out of 6 Years Active: 2003-2010
Title: The Innovative Journey of Tilmann Brandstetter
Introduction: Tilmann Brandstetter, a distinguished inventor based in Munich, Germany, has made significant contributions to the field of biochemistry and medicinal chemistry. With an impressive portfolio of 8 patents, his work emphasizes the development of innovative solutions for complex biomedical challenges.
Latest Patents: Among Brandstetter's latest innovations is a pivotal patent related to a "Process for preparing a pentopyranosyl nucleic acid conjugate." This invention outlines a detailed method for creating a conjugate that integrates a pentopyranosyl nucleic acid with a biomolecule. The process specifically involves linking pentopyranosyl nucleotide subunits, which are crucial for various biological applications. Another notable patent focuses on "Immunosuppressant compounds, methods and uses related thereto." This invention provides compositions and methodologies aimed at suppressing immune responses, particularly useful in the treatment of disorders such as rheumatoid arthritis and multiple sclerosis.
Career Highlights: Throughout his career, Tilmann Brandstetter has been associated with notable companies such as Nanogen and Recognomics GmbH, as well as Aventis Research & Technologies GmbH & Co. His experiences in these organizations have significantly shaped his innovative journey, enabling him to advance his research and development efforts effectively.
Collaborations: Brandstetter has had the opportunity to collaborate with esteemed colleagues in his field, including Christian Miculka and Norbert Windhab. These collaborations have fostered a dynamic exchange of ideas and expertise, further enhancing the impact of his inventions.
Conclusion: Tilmann Brandstetter's dedication to innovation is evident in his extensive patent portfolio and his impactful contributions to the scientific community. His work not only addresses critical biomedical issues but also paves the way for future advancements in immunology and biochemistry, solidifying his reputation as a leading inventor in his field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile